Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meyer-Monard

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Bone Marrow Transplantation|June 30, 2009
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignanciesG Stussi, J Halter, A Tichelli, et al.
Bone Marrow Transplantation|September 4, 2012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centersM Stern, J R Passweg, S Meyer-Monard, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETON Da Silva, S Meyer-Monard, M L Menot, et al.
Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.
Bone Marrow Transplantation|December 9, 2008
Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cellsS Meyer-Monard, J Passweg, C Troeger, et al.
Leukemia|May 13, 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Bone Marrow Transplantation|June 30, 2009
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignanciesG Stussi, J Halter, A Tichelli, et al.
Bone Marrow Transplantation|September 4, 2012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centersM Stern, J R Passweg, S Meyer-Monard, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETON Da Silva, S Meyer-Monard, M L Menot, et al.
Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.
Bone Marrow Transplantation|December 9, 2008
Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cellsS Meyer-Monard, J Passweg, C Troeger, et al.
Leukemia|May 13, 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.
Pageof 2